BAMCO INC /NY/ - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 116 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q3 2020$1,758,000
-29.7%
164,9000.0%0.01%
-44.4%
Q2 2020$2,500,000
+82.0%
164,9000.0%0.01%
+28.6%
Q1 2020$1,374,000
-68.7%
164,900
-36.6%
0.01%
-58.8%
Q4 2019$4,394,000
-9.0%
260,0000.0%0.02%
-15.0%
Q3 2019$4,828,000
-18.8%
260,0000.0%0.02%
-16.7%
Q2 2019$5,949,000
+8.9%
260,0000.0%0.02%
+4.3%
Q1 2019$5,465,000
+82.8%
260,0000.0%0.02%
+53.3%
Q4 2018$2,990,000260,0000.02%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Birchview Capital, LP 2,067,560$53,364,00028.19%
Selkirk Management LLC 208,000$5,368,0002.94%
Iguana Healthcare Management, LLC 270,000$6,969,0002.20%
Opaleye Management Inc. 100,600$2,596,0001.03%
Miura Global Management 600,000$15,486,0000.94%
DSC Advisors, L.P. 57,400$1,481,0000.77%
Cannell & Co. 1,016,828$26,244,0000.74%
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 276,549$7,138,0000.61%
Harvest Capital Strategies LLC 100,000$2,581,0000.33%
Raging Capital Management, LLC 93,932$2,424,0000.31%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders